Search research articles
Contact Us
Filters
Showing results (141-150 of 407) with videos related to
Page
of 41
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 17, 2012
A dramatic response to crizotinib in a non-small-cell lung cancer patient with IHC-positive and FISH-negative ALK
Jong-Mu Sun, Yoon-La Choi, Jae-Kyung Won, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 4, 2016
Heterogeneity of EGFR Aberrations and Correlation with Histological Structures: Analyses of Therapy-Naive Isogenic Lung Cancer Lesions with EGFR Mutation
Kenichi Suda, Isao Murakami, Hui Yu, et al.
Biorxiv : the Preprint Server for Biology
|
March 30, 2023
Role of Lactate in the Regulation of Transcriptional Activity of Breast Cancer-Related Genes and Epithelial-to-Mesenchymal Transition Proteins: A Compassion of MCF7 and MDA-MB-231 Cancer Cell Lines
Inigo San-Millan, Janel L Martinez, Shivaun Lueke Pickard, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
January 27, 2016
Hepatic Metastases is Associated with Poor Efficacy of Erlotinib as 2nd/3rd Line Therapy in Patients with Lung Adenocarcinoma
Yayi He, Yan Wang, Theresa Boyle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2008
Fluorescence in situ hybridization subgroup analysis of TRIBUTE, a phase III trial of erlotinib plus carboplatin and paclitaxel in non-small cell lung cancer
Fred R Hirsch, Marileila Varella-Garcia, Rafal Dziadziuszko, et al.
Translational Lung Cancer Research
|
February 4, 2020
Comparative expression analysis in small cell lung carcinoma reveals neuroendocrine pattern change in primary tumor versus lymph node metastases
Zoltan Lohinai, Zsolt Megyesfalvi, Kenichi Suda, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 26, 2016
cMET Exon 14 Skipping: From the Structure to the Clinic
Nele Van Der Steen, Elisa Giovannetti, Patrick Pauwels, et al.
Clinical Lung Cancer
|
May 20, 2017
Access to Cancer Specialist Care and Treatment in Patients With Advanced Stage Lung Cancer
Apar Kishor Ganti, Fred R Hirsch, Murry W Wynes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2015
Intratumoral Heterogeneity of ALK-Rearranged and ALK/EGFR Coaltered Lung Adenocarcinoma
Weijing Cai, Dongmei Lin, Chunyan Wu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 12, 2014
An international interpretation study using the ALK IHC antibody D5F3 and a sensitive detection kit demonstrates high concordance between ALK IHC and ALK FISH and between evaluators
Murry W Wynes, Lynette M Sholl, Manfred Dietel, et al.
Page
of 41
Search research articles
Search
Showing results (141-150 of 407) with videos related to
Sort By:
Page
of 41
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 17, 2012
A dramatic response to crizotinib in a non-small-cell lung cancer patient with IHC-positive and FISH-negative ALK
Jong-Mu Sun, Yoon-La Choi, Jae-Kyung Won, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 4, 2016
Heterogeneity of EGFR Aberrations and Correlation with Histological Structures: Analyses of Therapy-Naive Isogenic Lung Cancer Lesions with EGFR Mutation
Kenichi Suda, Isao Murakami, Hui Yu, et al.
Biorxiv : the Preprint Server for Biology
|
March 30, 2023
Role of Lactate in the Regulation of Transcriptional Activity of Breast Cancer-Related Genes and Epithelial-to-Mesenchymal Transition Proteins: A Compassion of MCF7 and MDA-MB-231 Cancer Cell Lines
Inigo San-Millan, Janel L Martinez, Shivaun Lueke Pickard, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
January 27, 2016
Hepatic Metastases is Associated with Poor Efficacy of Erlotinib as 2nd/3rd Line Therapy in Patients with Lung Adenocarcinoma
Yayi He, Yan Wang, Theresa Boyle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2008
Fluorescence in situ hybridization subgroup analysis of TRIBUTE, a phase III trial of erlotinib plus carboplatin and paclitaxel in non-small cell lung cancer
Fred R Hirsch, Marileila Varella-Garcia, Rafal Dziadziuszko, et al.
Translational Lung Cancer Research
|
February 4, 2020
Comparative expression analysis in small cell lung carcinoma reveals neuroendocrine pattern change in primary tumor versus lymph node metastases
Zoltan Lohinai, Zsolt Megyesfalvi, Kenichi Suda, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 26, 2016
cMET Exon 14 Skipping: From the Structure to the Clinic
Nele Van Der Steen, Elisa Giovannetti, Patrick Pauwels, et al.
Clinical Lung Cancer
|
May 20, 2017
Access to Cancer Specialist Care and Treatment in Patients With Advanced Stage Lung Cancer
Apar Kishor Ganti, Fred R Hirsch, Murry W Wynes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2015
Intratumoral Heterogeneity of ALK-Rearranged and ALK/EGFR Coaltered Lung Adenocarcinoma
Weijing Cai, Dongmei Lin, Chunyan Wu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 12, 2014
An international interpretation study using the ALK IHC antibody D5F3 and a sensitive detection kit demonstrates high concordance between ALK IHC and ALK FISH and between evaluators
Murry W Wynes, Lynette M Sholl, Manfred Dietel, et al.
Page
of 41